Corporate Member Update: Servier

Corporate Member Update: Servier

Voranigo
September, 2024

VORANIGO was approved by the FDA to treat mIDH glioma. Please review the information and trial highlights below.

Click here for this update!

 
 
Become a NOS Member Today!
Join Now
 

Platinum Corporate Members

Gold Corporate Members